Share-based Compensation (Tables)

3 Months Ended

Jun. 30, 2024

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Summary of share-based compensation expense

The following table summarizes the share-based compensation expense for restricted and performance grants included in the condensed consolidated statements of operations:

	Three months ended June 30,
(In thousands)	2024		2023
Product development		2,636		1,625
Sales and marketing		331		166
General and administrative		1,462		1,376
Total share-based compensation expense		4,429		3,167

Activity related SSARs award

The following table summarizes the activity during the three months ended June 30, 2024 for SSARs awarded under the 2020 and 2016 Plans:

(In thousands, except share and per share data)	Number of Rights			Weighted-Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
				(per right)		(in years)
Outstanding at April 1, 2024		1,297,339		$	27.63
Granted		—			—
Exercised		(737,136	)		33.48
Forfeited		—			—
Expired		—			—
Outstanding at June 30, 2024		560,203		$	19.94		3.3	$	47,169
Exercisable at June 30, 2024		560,203		$	19.94		3.3	$	47,169
Vested and expected to vest at June 30, 2024		560,203		$	19.94		3.3	$	47,169

Activity related to restricted shares awarded by the Company

The following table summarizes the activity during the three months ended June 30, 2024 for restricted shares awarded under the 2020 Plan:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2024		436,177		$	65.52
Granted		13,149			103.30
Vested		(79,792	)		53.51
Forfeited		(2,263	)		70.58
Outstanding at June 30, 2024		367,271		$	68.05

Employee Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of principal assumptions utilized in valuing service condition SARs

We estimate the value of the call and put options using the Black-Scholes-Merton option pricing model with inputs including the closing market price of our common stock on the first date of the offering period and assumptions regarding the risk-free interest rate, expected term, and expected volatility of our common shares over the offering period based on historical volatility.

	Offering Period Ended
	June 30, 2024
Grant date fair value	$	81.60
Risk-free interest rate over contractual term		5.36	%
Expected term (in years)		0.41
Expected volatility		47.41	%

Restricted Stock Units (RSUs) [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Activity related to restricted shares awarded by the Company

The following table summarizes the activity during three months ended June 30, 2024 for restricted stock units awarded under the 2020 Plan:

	Number of Shares		Weighted-Average Grant-Date Fair Value
			(per share)
Outstanding at April 1, 2024		56,547	$	70.03
Granted		—		—
Vested		—		—
Forfeited		—		—
Outstanding at June 30, 2024		56,547	$	70.03